Literature DB >> 18591180

The relation between cytokines, soluble endothelial protein C receptor, and factor VIII levels in Turkish pediatric stroke patients.

Denizay Yürürer1, Serap Teber, Gülhis Deda, Yonca Egin, Nejat Akar.   

Abstract

The aim of the authors is to examine the relationship between the cytokine levels that are thought to be involved in stroke etiopathogenesis (tumor necrosis factor [TNF]-alpha, interleukin [IL]-2, IL-6, IL-8, IL-11), soluble protein C receptor (sEPCR), and factor VIII (FVIII) levels. The study included 27 patients with stroke and 30 healthy controls, aged 0 to 18. In the comparison of the sEPCR, cytokine, and FVIII levels between patient and control groups, median levels of TNF-alpha, IL-2, IL-6, and IL-8 are found to be high in the patient group when compared with controls, whereas there is no difference in sEPCR, IL-11, and FVIII levels. In the patient group, a positive correlation is seen between TNF-alpha levels and IL-2 and IL-6 levels, between IL-2 and IL-6 levels, and between IL-6 and IL-8 levels, whereas a negative relationship is seen between sEPCR and FVIII. In the control group apart from the patient group, a negative relationship is seen between TNF-alpha and FVIII, whereas there is a positive relationship between IL-11 and sEPCR levels. Median sEPCR levels in patients who have normal or low FVIII levels are significantly high when compared with those with high FVIII levels. In conclusion, in the pediatric population, an increase in TNF-alpha, IL-2, IL-6, and IL-8 levels is seen. Also, an inverse relationship of sEPCR and FVIII levels is shown for the first time. This study provides a basis for ongoing studies that aim to clarify stroke etiopathogenesis. Studies with larger series of patients are warranted to confirm this hypothesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18591180     DOI: 10.1177/1076029608319880

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  8 in total

1.  Soluble endothelial protein C receptor levels in healthy population.

Authors:  Filiz Simsek Orhon; Huseyin Ergun; Yonca Egin; Betul Ulukol; Sevgi Baskan; Nejat Akar
Journal:  J Thromb Thrombolysis       Date:  2009-03-19       Impact factor: 2.300

2.  Relationship of late arteriovenous fistula stenosis with soluble E-selectin and soluble EPCR in chronic hemodialysis patients with arteriovenous fistula.

Authors:  Mukadder Ayse Bilgic; Hakki Yilmaz; Alper Bozkurt; Huseyin Tugrul Celik; Ismail Celal Bilgic; Ozgul Malcok Gurel; Ismail Kirbas; Nuket Bavbek; Ali Akcay
Journal:  Clin Exp Nephrol       Date:  2014-03-14       Impact factor: 2.801

3.  Endothelial protein C receptor and pediatric arterial stroke.

Authors:  Nejat Akar; Afife Karabıyık; Gülhis Deda
Journal:  Turk J Haematol       Date:  2013-03-05       Impact factor: 1.831

4.  The Dual Diverse Dynamic Reversible Effects of Ankaferd Blood Stopper on EPCR and PAI-1 Inside Vascular Endothelial Cells With and Without LPS Challenge.

Authors:  Afife Karabıyık; Erkan Yılmaz; Sükrü Güleç; Ibrahim Haznedaroğlu; Nejat Akar
Journal:  Turk J Haematol       Date:  2012-12-05       Impact factor: 1.831

Review 5.  Inflammatory responses in hypoxic ischemic encephalopathy.

Authors:  Fudong Liu; Louise D McCullough
Journal:  Acta Pharmacol Sin       Date:  2013-07-29       Impact factor: 6.150

6.  The Effects of Endothelial Protein C Receptor Gene Polymorphisms on the Plasma sEPCR Level in Venous Thrombosis Patients.

Authors:  Afife Karabıyık; Erkan Yılmaz; Yonca Eğin; Nejat Akar
Journal:  Turk J Haematol       Date:  2012-03-05       Impact factor: 1.831

7.  Ankaferd hemostat (ABS) as a potential mucosal topical agent for the management of COVID-19 syndrome based on its PAR-1 inhibitory effect and oestrogen content.

Authors:  Fatma Beyazit; Yavuz Beyazit; Alpaslan Tanoglu; Ibrahim C Haznedaroglu
Journal:  Med Hypotheses       Date:  2020-07-31       Impact factor: 1.538

8.  Cytokine production pattern of T lymphocytes in neonatal arterial ischemic stroke during the first month of life-a case study.

Authors:  Anna Bajnok; László Berta; Csaba Orbán; Tivadar Tulassay; Gergely Toldi
Journal:  J Neuroinflammation       Date:  2018-06-22       Impact factor: 8.322

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.